RWA Wealth Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,979
Closed -$212K 651
2026
Q1
$212K Buy
2,979
+76
+3% +$5.99K ﹤0.01% 604
2025
Q4
$238K Sell
2,903
-3,471
-54% -$270K ﹤0.01% 567
2025
Q3
$479K Buy
6,374
+165
+3% +$12.3K 0.01% 450
2025
Q2
$460K Buy
6,209
+1,719
+38% +$120K 0.01% 440
2025
Q1
$362K Sell
4,490
-191
-4% -$16.4K ﹤0.01% 452
2024
Q4
$366K Sell
4,681
-70,369
-94% -$5.98M ﹤0.01% 454
2024
Q3
$7.04M Buy
75,050
+70,247
+1,463% +$5.9M 0.09% 127
2024
Q2
$374K Sell
4,803
-119
-2% -$9.71K ﹤0.01% 427
2024
Q1
$447K Sell
4,922
-149
-3% -$12.4K 0.01% 406
2023
Q4
$392K Buy
+5,071
New +$355K 0.01% 405

Other funds holding GEHC

RWA Wealth Partners's GEHC Position: Q2 2026 in Review

RWA Wealth Partners sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 2,979 shares — an estimated $212K sold.

RWA Wealth Partners first reported a position in GEHC in Q4 2023 and held it in 10 quarters. The position peaked at $7.04M in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • RWA Wealth Partners reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • RWA Wealth Partners sold 2,979 GE HealthCare shares in Q2 2026, an estimated $212K.
  • RWA Wealth Partners first reported a position in GE HealthCare in Q4 2023 and held it in 10 quarters.
  • RWA Wealth Partners's GE HealthCare position peaked at $7.04M in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.